FDA teething tablet warning
On Jan. 27, the U.S. Food and Drug Administration (FDA) warned that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and…
Web Exclusives
Healthcare workforce needs
A special issue of Health Services Research discusses ways to prepare workers to improve the delivery, quality, and cost of U.S. health care. Read…
FDA approves new drug for CIC
On Jan. 29, the U.S. Food and Drug Administration (FDA) approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation. Read more
MRI may help predict response to antidepressants
A functional MRI brain scan may help predict which patients will respond positively to antidepressant therapy, according to a study in Brain. Read more and read…
Exercise guidelines for patients with type 1 diabetes
Access “Exercise management in type 1 diabetes: a consensus statement” in The Lancet Diabetes & Endocrinology. Read more
New guideline for treating hypertension
The Annals of Internal Medicine has published a new guideline on the pharmacologic treatment of hypertension in adults 60 years or older and target…
FDA, EPA releases fish consumption advice for specific groups
The Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) have released guidance for fish consumption; the guidelines are targeted to women…
Cannabis use in older adults
An article in The Gerontologist discusses the implications of the rising use of cannabis in older Americans. Read more
ADA releases position statement on diabetic neuropathy
The American Diabetes Association (ADA) has released a position statement on diabetic neuropathy that outlines recommendations for preventing and managing the condition. Read more
Patient on the precipice
Richard Hamilton, age 67, is admitted to the telemetry unit from the emergency department (ED) with new-onset chest pain. In the ED, his troponin test…
FDA approves first drug for treating spinal muscular dystrophy
On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular…
FDA teething tablet warning
On Jan. 27, the U.S. Food and Drug Administration (FDA) warned that homeopathic teething tablets containing belladonna pose an unnecessary risk to…
Healthcare workforce needs
A special issue of Health Services Research discusses ways to prepare workers to improve the delivery, quality, and cost of U.S. health…
FDA approves new drug for CIC
On Jan. 29, the U.S. Food and Drug Administration (FDA) approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation. Read more
MRI may help predict response to antidepressants
A functional MRI brain scan may help predict which patients will respond positively to antidepressant therapy, according to a study in Brain. Read…
Exercise guidelines for patients with type 1 diabetes
Access “Exercise management in type 1 diabetes: a consensus statement” in The Lancet Diabetes & Endocrinology. Read more
New guideline for treating hypertension
The Annals of Internal Medicine has published a new guideline on the pharmacologic treatment of hypertension in adults 60 years or older…
FDA, EPA releases fish consumption advice for specific groups
The Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) have released guidance for fish consumption; the guidelines are targeted…
Cannabis use in older adults
An article in The Gerontologist discusses the implications of the rising use of cannabis in older Americans. Read more
ADA releases position statement on diabetic neuropathy
The American Diabetes Association (ADA) has released a position statement on diabetic neuropathy that outlines recommendations for preventing and managing the condition.…
Patient on the precipice
Richard Hamilton, age 67, is admitted to the telemetry unit from the emergency department (ED) with new-onset chest pain. In the ED, his…
FDA approves first drug for treating spinal muscular dystrophy
On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.